Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies

The risks of overusing short-acting β(2)-agonists (SABA), including an increase in asthma-related deaths, are many and well known. The Global Initiative on Asthma (GINA) 2019 and 2020 updates recommend as-needed inhaled corticosteroid (ICS)/formoterol as the preferred rescue medication in mild asthm...

Descripción completa

Detalles Bibliográficos
Autores principales: Canonica, Giorgio Walter, Paggiaro, Pierluigi, Blasi, Francesco, Musarra, Antonino, Richeldi, Luca, Rossi, Andrea, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488406/
https://www.ncbi.nlm.nih.gov/pubmed/34587829
http://dx.doi.org/10.1177/17534666211042534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488406/
https://www.ncbi.nlm.nih.gov/pubmed/34587829
http://dx.doi.org/10.1177/17534666211042534

Ejemplares similares